Brentuximab Vedotin (SGN-35) in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma: A Phase 2 Study Update Advani, R. H., Shustov, A. R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M. A., Connors, J. M., Yang, Y., Kennedy, D. A., Pro, B. AMER SOC HEMATOLOGY. 2011: 204

View details for Web of Science ID 000299597100444